Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership
Learn More
close
Fred Hutch - Cures Start Here®
Research
Pioneering Scientific Research
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Submit
Donate
Now
Submit
Research
Pioneering Scientific Research
Research Areas
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Donate Now
Hutch News
Science Spotlight
News Releases
Scientific Publications
For the Media
Media Coverage
Stories tagged Daniel Lin
Results per Page:
20
5
10
20
50
100
African Americans and the risk of reclassification in Active Surveillance
From the Lin Group, Division of Public Health Sciences
Science Spotlight - December 16, 2019
Tags
Public Health Sciences Division (PHS)
Daniel Lin
Prostate Cancer
canary prostate active surveillance study
Share
Black men with early-stage prostate cancer can do active surveillance
New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men
Hutch News - November 27, 2019
Tags
Prostate Cancer
Institute for Prostate Cancer Research
canary prostate active surveillance study
Canary Foundation
Daniel Lin
Peter Nelson
Public Health Sciences
active surveillance
Human Biology
Share
Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study
Hutch News - November 22, 2019
Tags
Public Health Sciences
Prostate Cancer
Daniel Lin
Canary Foundation
canary prostate active surveillance study
nci
national cancer institutes
Tumor specific translational research
Good News
Share
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
Hutch News - May 14, 2019
Tags
IPCR
Prostate Cancer
health disparities
Peter Nelson
Marian Neuhouser
Heather Cheng
Evan Yu
Daniel Lin
diet disease association
Health Risks and Benefits of Dietary Supplements
precision medicine
PET scan
immunotherapy
checkpoint inhibitors
BRCA
John Lee
genetic test
Human Biology
Clinical Research
Tumor specific translational research
Share
What’s new in prostate cancer? 5 things to watch
Highlights from the Institute for Prostate Cancer Research 2017 community symposium
Hutch News - March 22, 2017
Tags
immunotherapy
Transplant and Immunotherapy
Cancer etiology - prevention - outcomes
Molecular basis of cancer
Tumor specific translational research
Prostate Cancer
Institute for Prostate Cancer Research
exercise
cancer imaging
personalized medicine
genomics
Elahe Mostaghel
Jonathan Wright
Heather Cheng
Daniel Lin
Evan Yu
Share
Expressing the potential for prostate cancer death
From the Stanford Lab, Public Health Sciences Division.
Science Spotlight - March 20, 2017
Tags
Janet L Stanford
Daniel Lin
Jonathan Wright
Prostate Cancer
prostate cancer progression
molecular epidemiology
Share
6 things men need to know about prostate cancer
Experts share their insight on screening, treatment, clinical trials and more
Hutch News - April 14, 2015
Tags
Prostate Cancer
prostate cancer prevention
Marian Neuhouser
Ruth Etzioni
Daniel Lin
SCCA
Seattle Cancer Care Alliance
Fred Hutch
fred hutchinson cancer research center
canary prostate active surveillance study
Clinical Research
Public Health Sciences
STTR cancer
Share
Validation of biomarkers for active surveillance of prostate cancer
Science Spotlight - May 20, 2013
Tags
biomarker
Prostate Cancer
Daniel Lin
Public Health Sciences
Share
Investigational urine test can predict aggressive prostate cancer
Daniel Lin study shows two biomarkers in urine are associated with cancers likely to be aggressive among men who take a 'watchful waiting' approach
Hutch News - February 06, 2012
Tags
tumor
cancer research
Public Health Sciences
urine analysis
Daniel Lin
fred hutchinson cancer research center
active surveillance
urine-based biomarkers
Share
Study shows an investigational urine test can predict high-risk prostate cancer in men who choose ‘watchful waiting’
News Releases - February 02, 2012
Tags
canary prostate active surveillance study
prostate biopsy
Prostate Cancer
active surveillance
Public Health Sciences
Daniel Lin
Canary Foundation
PSA
digital rectal exam
urine-based biomarkers
gleason score
fred hutchinson cancer research center
Share
Advanced prostate cancer and the age factor
Seattle Cancer Care Alliance physicians design University of Washington-based study to examine association between age at prostate-cancer diagnosis and health outcomes
Hutch News - June 08, 2009
Tags
screening
Prostate Cancer
prognosis
University of Washington
Seattle Cancer Care Alliance
Daniel Lin
fred hutchinson cancer research center
Share
Human Biology's Nelson receives Prostate Cancer Foundation award
Hutch News - April 06, 2006
Tags
Human Biology
Prostate Cancer
Peter Nelson
Daniel Lin
Share
Fred Hutchinson Cancer Center
Hutch News
Last Modified, April 02, 2020